Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Arndt Vogel

Hannover Medical School

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Biostatistics Biostatistics professors in Germany

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Collaborators (25)

John Bridgewater

UCL Cancer Institute

UNITED KINGDOM

View details

Mariano Ponz-Sarvise

Universidad de Navarra

SPAIN

View details

Luke Boulter

Reader

University of Edinburgh

UNITED KINGDOM

View details

Fabian Finkelmeier

University Hospital Frankfurt

GERMANY

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Hong Jae Chon

Associate Professor

CHA Bundang Medical Center

SOUTH KOREA

View details

Ferran Torres

Associate Professor. Head of Unit

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Salvatore Corallo

Researcher

University of Pavia

ITALY

View details

Benjamin Dwyer

Senior Research Fellow

Curtin University

AUSTRALIA

View details

Maria Reig

Director

University of Barcelona

SPAIN

View details

Stephen Pereira

University College London

UNITED KINGDOM

View details

Silvia Affo

Junior Group Leader

idibaps

SPAIN

View details

Grainne M. O'Kane

University College Dublin

IRELAND

View details

Shahid Khan

Professor of Practice

Imperial College London

UNITED KINGDOM

View details

ilhwan kim

Associate Professor

Inje University Ilsan Paik Hospital

SOUTH KOREA

View details

Sergio A. Gradilone

Faculty, Professor

University of Minnesota

UNITED STATES

View details

LUCA FABRIS

Associate Professor

Yale University

UNITED STATES

View details

Jin Won Kim

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Giovanni Farinea

University of Turin

ITALY

View details

Guido CARPINO

Università degli Studi di Roma La Sapienza

ITALY

View details

Sara Lonardi

Head of Dept

Istituto Oncologico Veneto

ITALY

View details

Taotao Zhou

University Hospital Bonn

GERMANY

View details

Monica Niger

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Lorenzo Antonuzzo

University of Florence

ITALY

View details

Lorenza Rimassa

Head of Hepatopancreatobiliary Oncology Unit

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arndt Vogel

Research Interests

Explore related searches

Articles (20)

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

Perioperative approaches for patients with biliary tract cancer

Cholangiocarcinoma 2026: status quo, unmet needs and priorities

Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study

Diagnosis and treatment of pancreatic cancer: an expert opinion from the 9th CECOG Pancreas Cancer Academy

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial

Transarterial Chemoembolization Combined with Immunotherapy-Based Systemic Therapy for Hepatocellular Carcinoma: An International ISMIO Expert Consensus Framework

Systemic therapy for HCC: Doublets, triplets and beyond

Real-world data from patients treated with chemotherapy for biliary tract cancer: insights from a prognostic model. ☆

Global biliary tract cancer genomics: From geographic patterns toward biological subtypes

Sequencing of Fibroblast Growth Factor Receptor Inhibitors in Cholangiocarcinoma: A Review of Published Cases

Beyond hazard ratios: interpreting trial endpoints and survival analysis in systemic therapy for hepatocellular carcinoma

Nivolumab in combination with lenvatinib in unresectable hepatocellular carcinoma: The IKF-t006/IMMUNIB translational phase-2 study

Perioperative immunotherapy to reduce recurrence in resectable hepatocellular carcinoma - lessons learned from the CARES-009 trial

Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction‐Associated Steatohepatitis Patients

Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studies

Navigating second-line therapy after immunotherapy in advanced HCC☆

Adjuvant pembrolizumab for participants with hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation: The phase 3 keynote-937 study

Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC

BCLC strategy for prognosis prediction and treatment recommendations

Collaborators (25)

John Bridgewater

Mariano Ponz-Sarvise

Luke Boulter

Fabian Finkelmeier

David J. Pinato

Hong Jae Chon

Ferran Torres

Salvatore Corallo

Benjamin Dwyer

Maria Reig

Stephen Pereira

Silvia Affo

Grainne M. O'Kane

Shahid Khan

ilhwan kim

Sergio A. Gradilone

LUCA FABRIS

Jin Won Kim

Giovanni Farinea

Guido CARPINO

Sara Lonardi

Taotao Zhou

Monica Niger

Lorenzo Antonuzzo

Lorenza Rimassa

Make your next move.